| 000 | 01283 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513062013.0 | ||
| 264 | 0 | _c19940405 | |
| 008 | 199404s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410350330 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeyer, M A | |
| 245 | 0 | 0 |
_aIntravenously administered dopamine transporter site radioligand is not significantly retained in mouse substantia nigra or other sites outside of basal ganglia. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cMar 1994 |
||
| 300 |
_a378-9 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasal Ganglia _xmetabolism |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCocaine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNerve Tissue Proteins |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aSubstantia Nigra _xmetabolism |
| 700 | 1 | _aGoodman, M M | |
| 773 | 0 |
_tAnnals of neurology _gvol. 35 _gno. 3 _gp. 378-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410350330 _zAvailable from publisher's website |
| 999 |
_c8122221 _d8122221 |
||